Cargando…

The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes

BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Nor Azlan, Docherty, Paul D, Krebs, Jeremy D, Bell, Damon A, Chase, J Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350631/
https://www.ncbi.nlm.nih.gov/pubmed/25881031
http://dx.doi.org/10.1186/s12938-015-0015-7
_version_ 1782360211882770432
author Othman, Nor Azlan
Docherty, Paul D
Krebs, Jeremy D
Bell, Damon A
Chase, J Geoffrey
author_facet Othman, Nor Azlan
Docherty, Paul D
Krebs, Jeremy D
Bell, Damon A
Chase, J Geoffrey
author_sort Othman, Nor Azlan
collection PubMed
description BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitability the DISST model has for individuals with established type 2 diabetes (T2D). METHODS: 14 participants with established T2D were recruited to take part in a dietary intervention study. Insulin-modified intravenous glucose tolerance tests (IM-IVGTT) were undertaken at week 0, 12 and 24 and were used with DISST model to identify G(B). A total of 36 tests were conducted across 12 participants throughout the study. Measured G(0) and identified G(B) values were compared using a Kolmogorov-Smirnov (KS) and signed rank (RS) test for the cohort. RESULTS: There were significant differences between the G(0) and identified G(B) values in this cohort (p(rs) and p(ks) < 0.0001), although both values were well correlated (R = 0.70). The residual plot demonstrates that the modified model captures the behaviour of the participants more accurately than the original model. CONCLUSIONS: This analysis has shown that G(B) is an important variable for modelling the glycaemic behaviour in T2D. These findings suggest that the original DISST model, while appropriate for normoglycaemic cohorts, needs to model basal glucose level as a variable for assessing individuals with established T2D.
format Online
Article
Text
id pubmed-4350631
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43506312015-03-06 The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes Othman, Nor Azlan Docherty, Paul D Krebs, Jeremy D Bell, Damon A Chase, J Geoffrey Biomed Eng Online Research BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitability the DISST model has for individuals with established type 2 diabetes (T2D). METHODS: 14 participants with established T2D were recruited to take part in a dietary intervention study. Insulin-modified intravenous glucose tolerance tests (IM-IVGTT) were undertaken at week 0, 12 and 24 and were used with DISST model to identify G(B). A total of 36 tests were conducted across 12 participants throughout the study. Measured G(0) and identified G(B) values were compared using a Kolmogorov-Smirnov (KS) and signed rank (RS) test for the cohort. RESULTS: There were significant differences between the G(0) and identified G(B) values in this cohort (p(rs) and p(ks) < 0.0001), although both values were well correlated (R = 0.70). The residual plot demonstrates that the modified model captures the behaviour of the participants more accurately than the original model. CONCLUSIONS: This analysis has shown that G(B) is an important variable for modelling the glycaemic behaviour in T2D. These findings suggest that the original DISST model, while appropriate for normoglycaemic cohorts, needs to model basal glucose level as a variable for assessing individuals with established T2D. BioMed Central 2015-03-03 /pmc/articles/PMC4350631/ /pubmed/25881031 http://dx.doi.org/10.1186/s12938-015-0015-7 Text en © Othman et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Othman, Nor Azlan
Docherty, Paul D
Krebs, Jeremy D
Bell, Damon A
Chase, J Geoffrey
The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title_full The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title_fullStr The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title_full_unstemmed The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title_short The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
title_sort necessity of identifying the basal glucose set-point in the ivgtt for patients with type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350631/
https://www.ncbi.nlm.nih.gov/pubmed/25881031
http://dx.doi.org/10.1186/s12938-015-0015-7
work_keys_str_mv AT othmannorazlan thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT dochertypauld thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT krebsjeremyd thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT belldamona thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT chasejgeoffrey thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT othmannorazlan necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT dochertypauld necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT krebsjeremyd necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT belldamona necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes
AT chasejgeoffrey necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes